Company Profile
Synaptixbio Ltd
13318389•Private Limited With Share Capital
Get Full Access
07/04/2021
5 years
6
3
72110
low risk
Company Overview
Registration, classification & business activity
Synaptixbio Ltd (13318389) is a private limited with share capital incorporated on 07/04/2021 (5 years old) and registered in oxford, OX42HN. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Overviewsynaptixbio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. synaptixbio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or muta...
Financial Overview
£3.78M
£217.8K
£3.56M
£2.33M
Key Metrics
3
Employees
6
Directors
18
Shareholders
Board of Directors
Innovate Grants
This company received a grant of £498602.0 for The Treatment Of Rare Paediatric Tubb4A-Related Leukodystrophiescs For The Treatment Of Rare Paediatric Tubb4A-Related Leukodystrophies. The project started on 01/11/2023 and ended on 31/10/2025.
This company received a grant of £1999008.0 for The Treatment Of A Rare Paediatric Tubb4A-Related Leukodystrophy - A First-In-Human Clinical Triale Paediatric Tubb4A-Related Leukodystrophy - A First-In-Human Clinical Trial. The project started on 01/07/2024 and ended on 31/12/2027.
Risk Assessment
low risk
International Score
Future Factor
excellent
Performance Rating